BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32049075)

  • 21. Novel tetranuclear ruthenium(II) arene complexes showing potent cytotoxic and antimetastatic activity as well as low toxicity in vivo.
    Mohamed Subarkhan MK; Ren L; Xie B; Chen C; Wang Y; Wang H
    Eur J Med Chem; 2019 Oct; 179():246-256. PubMed ID: 31255925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, characterization and anticancer mechanism studies of fluorinated cyclometalated ruthenium(ii) complexes.
    Wen Y; Ouyang C; Li Q; Rees TW; Qiu K; Ji L; Chao H
    Dalton Trans; 2020 Jun; 49(21):7044-7052. PubMed ID: 32406463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.
    Ma L; Ma R; Wang Z; Yiu SM; Zhu G
    Chem Commun (Camb); 2016 Sep; 52(71):10735-8. PubMed ID: 27506281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Macrocyclic Ruthenium(III) Complex Inhibits Angiogenesis with Down-Regulation of Vascular Endothelial Growth Factor Receptor-2 and Suppresses Tumor Growth In Vivo.
    Kwong WL; Lam KY; Lok CN; Lai YT; Lee PY; Che CM
    Angew Chem Int Ed Engl; 2016 Oct; 55(43):13524-13528. PubMed ID: 27717148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents.
    Ma W; Guo L; Tian Z; Zhang S; He X; Li J; Yang Y; Liu Z
    Dalton Trans; 2019 Apr; 48(15):4788-4793. PubMed ID: 30892340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Platinum (II) Ternary Complexes of Formamidine and Pyrophosphate: Synthesis, Characterization and DFT Calculations and
    Soliman AA; Attaby FA; Alajrawy OI; Abou-Hussein AAA; Linert W
    Comb Chem High Throughput Screen; 2020; 23(7):611-623. PubMed ID: 32067614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
    Zhang X; Liu D; Lv F; Yu B; Shen Y; Cong H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110373. PubMed ID: 31376689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells.
    Qu F; Park S; Martinez K; Gray JL; Thowfeik FS; Lundeen JA; Kuhn AE; Charboneau DJ; Gerlach DL; Lockart MM; Law JA; Jernigan KL; Chambers N; Zeller M; Piro NA; Kassel WS; Schmehl RH; Paul JJ; Merino EJ; Kim Y; Papish ET
    Inorg Chem; 2017 Jul; 56(13):7519-7532. PubMed ID: 28636344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles.
    Novak MS; Büchel GE; Keppler BK; Jakupec MA
    J Biol Inorg Chem; 2016 Jun; 21(3):347-56. PubMed ID: 26961253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of NNN Chiral Ruthenium Complexes and Their Cytotoxicity Studies.
    Nandi PG; Jadi PK; Das K; Prathapa SJ; Mandal BB; Kumar A
    Inorg Chem; 2021 May; 60(10):7422-7432. PubMed ID: 33909427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel ruthenium(II)-polypyridyl complex inhibits cell proliferation and induces cell apoptosis by impairing DNA damage repair.
    Yang Q; Zhang Z; Mei W; Sun F
    J Chemother; 2014 Aug; 26(4):235-42. PubMed ID: 24070188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal.
    Cuello-Garibo JA; Meijer MS; Bonnet S
    Chem Commun (Camb); 2017 Jun; 53(50):6768-6771. PubMed ID: 28597879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coordination Chemistry of Organoruthenium Compounds with Benzoylthiourea Ligands and their Biological Properties.
    Parveen S; Tong KKH; Khawar Rauf M; Kubanik M; Shaheen MA; Söhnel T; Jamieson SMF; Hanif M; Hartinger CG
    Chem Asian J; 2019 Apr; 14(8):1262-1270. PubMed ID: 30706633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexes.
    Marloye M; Inam H; Moore CJ; Debaille V; Pritchard JR; Gelbcke M; Meyer F; Dufrasne F; Berger G
    J Biol Inorg Chem; 2021 Aug; 26(5):535-549. PubMed ID: 34173882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Illuminating cytochrome P450 binding: Ru(ii)-caged inhibitors of CYP17A1.
    Li A; Yadav R; White JK; Herroon MK; Callahan BP; Podgorski I; Turro C; Scott EE; Kodanko JJ
    Chem Commun (Camb); 2017 Mar; 53(26):3673-3676. PubMed ID: 28304025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ruthenium arene complexes in the treatment of 3D models of head and neck squamous cell carcinomas.
    Santi M; Mapanao AK; Biancalana L; Marchetti F; Voliani V
    Eur J Med Chem; 2021 Feb; 212():113143. PubMed ID: 33445155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
    Marzano C; Mazzega Sbovata S; Gandin V; Colavito D; Del Giudice E; Michelin RA; Venzo A; Seraglia R; Benetollo F; Schiavon M; Bertani R
    J Med Chem; 2010 Aug; 53(16):6210-27. PubMed ID: 20681543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumoral synergism between a copper(II) complex and cisplatin improves in vitro and in vivo anticancer activity against melanoma, lung and breast cancer cells.
    Mariani D; Ghasemishahrestani Z; Freitas W; Pezzuto P; Costa-da-Silva AC; Tanuri A; Kanashiro MM; Fernandes C; Horn A; Pereira MD
    Biochim Biophys Acta Gen Subj; 2021 Oct; 1865(10):129963. PubMed ID: 34246719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.